DBV Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!

About DBVT

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. 

CEO
Daniel Tassé
CEODaniel Tassé
Employees
109
Employees109
Headquarters
Chatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded
2002
Founded2002
Employees
109
Employees109

DBVT Key Statistics

Market cap
472.39M
Market cap472.39M
Price-Earnings ratio
-2.74
Price-Earnings ratio-2.74
Dividend yield
Dividend yield
Average volume
212.33K
Average volume212.33K
High today
$16.95
High today$16.95
Low today
$15.75
Low today$15.75
Open price
$16.81
Open price$16.81
Volume
223.66K
Volume223.66K
52 Week high
$18.00
52 Week high$18.00
52 Week low
$2.20
52 Week low$2.20

DBVT News

TipRanks 3d
Optimistic Outlook for DBV Technologies Amid Promising Viaskin Peanut Advancements

In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on DBV Technologies SA – American, with a price target of $19.00. Elevate Y...

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
0%
Sell
16.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.